This research in adults with insulin-treated type 2 diabetes who underwent RYGB (n=3318) or LAGB (n=1907) compared postsurgical changes in insulin treatment. Compared with LAGB, RYGB was associated with a significantly greater insulin cessation rate at 12 months (62% vs. 34% [p<0.001]), with a regression analysis showing that RYGB was a strong predictor of insulin cessation at both 1 month and 12 months. In a case-matched analysis at 3 months, RYGB continued to be associated with a higher rate of insulin cessation compared with LAGB (p=0.03), and the rate of diabetes remission was greater at all postsurgery timepoints. RYGB predicted insulin therapy cessation early postsurgery independently of bodyweight, whereas insulin cessation was linked to bodyweight loss after LAGB.
Welcome to issue 94 of Diabetes and Obesity Research Review.
This issue begins with research in patients with type 2 diabetes who had undergone bariatric surgery reporting higher rates of insulin cessation following RYGB than after LAGB. A paper from JAMA reports that offspring of mothers who have gestational diabetes diagnosed by 26 weeks' gestation seem to have a higher risk of developing an ASD (autism spectrum disorder). Two papers focus on type 1 diabetes-associated coeliac disease, one of which reports on a high rate of spontaneous coeliac serology normalisation in children, and the other describes an association between the presence of coeliac disease and the development of microvascular complications. Thank you for the comments, questions and suggestions you have sent -please keep them coming. Best Comment: This is likely to be a very emotive issue. The possible association between diabetes and autism is not a new question. In this retrospective cohort study, rates of autism in offspring were compared between women with pre-existing diabetes during pregnancy, those with gestational diabetes, either diagnosed before or after 26 weeks, and those without diabetes. The initial signal that pre-existing diabetes and early-onset gestational diabetes were associated with greater risk of autism was attenuated when adjusted for multiple confounders, to the point that of the three diabetes states, only early-onset gestational diabetes remained significantly associated with autism. Whilst this raises questions, it seems most unusual that only this specific diabetic state, arbitrarily defined from a continuum, is specifically a causal factor. Interesting questions, but I don't believe we have the answer. : JAMA 2015; 313(14) :1425-34 Abstract
Reference

Efficacy of commercial weight-loss programs
Authors: Gudzune KA et al.
Summary:
This was an updated systematic review of 45 studies (39 randomised controlled trials) comparing commercial or proprietary weight-loss programmes with no intervention, education or behavioural counselling in overweight and obese adults. The following increases in proportions of participants achieving bodyweight loss were seen: i) 2.6% at 12 months for Weight Watchers programmes versus control/education; ii) 4.9% at 12 months for Jenny Craig programmes versus control/education and counselling; iii) ≥3.8% at 3 months for Nutrisystem programmes versus control/education and counselling; iv) ≥4.0% (short-term) for very-low-calorie programmes versus counselling, but with some evidence of attenuation after 6 months; and v) 0.1-2.9% at 12 months for Atkins diets versus counselling. Other commercial weight-loss programmes evaluated had mixed findings or limited data.
Comment:
In the face of the obesity epidemic, health providers are struggling to provide effective weight loss programmes for patients. However, we might well ask whether this is actually our role? Whilst there are some individuals for who rapid weight loss may have health risks, for the large part weight loss achieved by any of the multitude of diets advertised and sold in books and commercial programmes is of health benefit. This systematic review aimed to examine the efficacy of these programmes, and demonstrated this. However, it is important to note that the quality of the trials reported was relatively low, particularly the short duration and high dropout rates. Many weight loss trials demonstrate the need for ongoing contact to maintain weight lost.
That may simply mean that individuals need to maintain involvement in the commercial programme of their choice. The big question here is who should pay for this?
Reference: Ann Intern Med 2015;162 (7) Metformin prescription for insured adults with prediabetes from 2010 to 2012 Authors: Moin T et al.
Summary:
The use of metformin in prediabetes was investigated in a retrospective cohort of 17,352 adult Americans with the condition from a private insurance database. Metformin was prescribed to 3.7% of the patients during the 3-year study period. After adjustments, metformin was twice as likely to be prescribed to women and obese patients, and 1.5 times as likely to be prescribed to patients with ≥2 comorbidities.
Comment: What to do with prediabetes? In NZ the estimated rate of prediabetes is 25% -only marginally lower than in America. Currently there is no clear pathway for people with prediabetes. Many individual practices and PHOs have some form of lifestyle programme, but there is no systematic national plan. I am often asked about the use of metformin for these patients. Yes there is evidence of reduced progression to diabetes, but equally we are then treating people with the drug we would start for diabetes anyway. It is therefore of great interest to me that in the US, where I would have expected a much greater use of drugs, only 3% of the prediabetic population studied were prescribed metformin. We need better research in this area, but I would be restricting the use to those on the verge of diabetes (HbA1c 45-49 mmol/mol) who had really tried all lifestyle options (see previous paper on commercial programmes). This is of course just an opinion in an evidence-free zone. Summary: Current practices for gestational diabetes screening in Cook Island women were reported using data from antenatal care attendees during 2009-2012. Screening involved a nonfasting 50g glucose challenge at 24-28 weeks' gestation, which if positive (1-hour glucose level ≥7.8 mmol/L) was followed by a 75g oral glucose tolerance test. Gestational diabetes was diagnosed if fasting glucose level was ≥5.2 mmol/L or 2-hour glucose level ≥8.0 mmol/L, and pregnancy impaired glucose tolerance was diagnosed on a positive screen and negative diagnostic test. The screening programme uptake had increased from 49.0% to 99.6% at the end of the study period. Among women who underwent a glucose challenge (n=646), 18% had a positive result and 13.8% had an oral glucose tolerance test. Pregnancy impaired glucose tolerance was diagnosed in 13.8% of these women, and gestational diabetes in 13.9%. Women with gestational diabetes and normal glucose tolerance had respective bodyweight gains of 6kg and 10kg and caesarean section rates of 25% and 11%; baby birthweights did not differ significantly. Among 59 women with gestational diabetes who underwent a postnatal glucose tolerance test at their 6-week check, diabetes was confirmed in 35.6%.
Comment: I have included a number of studies in recent issues of Diabetes Research Review highlighting the controversy around gestational diabetes. This study gives this a new perspective. Women in the Cook Islands are at high risk of diabetes, due to family history and high rates of obesity. However, previously there were low rates of uptake of screening for gestational diabetes. After initiating a more systematic screening programme, this increased to almost 100%, and with the exception of more caesarean sections, pregnancy outcomes became similar to women without gestational diabetes. This highlights that the greatest benefits probably come from better implementation of current guidelines and diagnostic criteria than lowering thresholds and overburdening women and the healthcare system. High rate of spontaneous normalization of celiac serology in a cohort of 446 children with type 1 diabetes Authors: Castellaneta S et al.
The prevalence of spontaneous normalisation of anti-tTG (antitissue transglutaminase) levels and predictors of this were prospectively investigated in 446 children screened for coeliac disease at onset of type 1 diabetes and specified intervals thereafter. Among children who became positive for coeliac serology (n=65), 58% had a persistently elevated anti-tTG titre, 41% had a fluctuating anti-tTG titre and 28% became negative. Positive coeliac disease autoimmunity and overt coeliac disease occurred at prevalences of 14.3% and 8.5%, respectively, values that are 15-and 8-times greater than seen in the general paediatric population. The lowest risk of developing coeliac disease was evident in asymptomatic children who were aged >9.1 years at type 1 diabetes onset.
Comment: Coeliac disease is increasing in prevalence. Whether this is a true increase, increased detection or even true coeliac disease is unknown. However, we now commonly screen for it in people with type 1 diabetes, particularly in children, adolescents and young adults. A diagnosis of coeliac disease has a profound impact on a person's life, particularly when combined with type 1 diabetes. Therefore the findings of this paper are of great interest. Here 40% of children with positive transglutaminase antibodies, but no symptoms, reverted to a negative state after 6 months. They may of course become positive later and/or develop true disease, but this is a large proportion of children for whom dietary restrictions can be avoided. I would be interested to know if there are similar data for adults diagnosed with type 1 diabetes. Privacy Policy: Research Review will record your details on a secure database and will not release them to anyone without prior approval. You have the right to inspect, update or delete your details at any time.
Disclaimer: This publication is not intended as a replacement for regular medical education but to assist in the process. The reviews are a summarised interpretation of the published study and reflect the opinion of the writer rather than those of the research group or scientific journal. It is suggested readers review the full trial data before forming a final conclusion on its merits. .2% for overweight and 5.7% and 4.7% for obese. Children of Pacific and Māori ethnicity and those from more socioeconomically deprived areas had higher prevalences of overweight and obesity than other children. There were no definite time trends seen over the study period.
Comment: One-third of 4-to 5-year-old children in NZ are overweight or obese! Yet we are still getting lip service from the government about the problem. In almost 9 years of the 'antinanny state' approach to education and selfresponsibility, we have seen no change in the course of obesity in this country either in adults or children. Surely the time has come for more robust measures. The very fact that the media are covering calls for lolly bans in dairies in Auckland indicates a level of public awareness and concern that something needs to be done. We must keep the pressure up. Regulation as part of a broad strategy is required. Bring on the sugar tax. Let's start somewhere.
Reference: J Paediatr Child Health 2015;51 (3) 
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